Deric M. Park

Deric M. Park

Auto-generated profile, based on publicly available information

Deric M. Park

Division of Neuro-Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
ASAkio Soeda
Akio Soeda
JLJustin Lathia
Justin Lathia
BWBrian Willliams
Brian Willliams
QWQiulian Wu
Qiulian Wu
JGJoseph Gallagher
Joseph Gallagher
DPDeric M. Park
Deric M. Park
The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking The p38 signaling pathway effects quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking

1 January 2008
Verified
Book Chapter
Closed access
PDF file
AAAndreas Androutsellis-Theotokis
Andreas Androutsellis-Theotokis
SMSachiko Murase
Sachiko Murase
JBJustin D. Boyd
Justin D. Boyd
DPDeric M. Park
Deric M. Park
DHDaniel J. Hoeppner
Daniel J. Hoeppner
RMRonald D.G. McKay
Ronald D.G. McKay

23 July 2024 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
YLYifan Lv
Yifan Lv
YDYuxuan Deng
Yuxuan Deng
JFJie Feng
Jie Feng
JLJinqiu Liu
Jinqiu Liu
MYMingxu Yang
Mingxu Yang
SHShuyu Hao
Shuyu Hao
Surgical resection followed by radiotherapy (RT) is recommended for malignant meningioma, but poor outcome is unavoidable. To improve the efficacy of RT in malignant meningioma, a targeted radiosensitizer can be added. Nicotinamide phosphoribosyltransferase (NAMPT), highly expressed in high-grade meningiomas, may play a role in determining the radioresponse. Herein, we evaluated the impact of NAMPT inhibition on radiosensitivity in malignant meningioma in vivo and in vitro. IOMM-Lee and TTMM705 cells were treated with NAMPT inhibition (FK866 or shRNA NAMPT) before irradiation. The subsequent clonogenic assay demonstrated significantly increased radiosensitivity. Combination treatment with FK866 and irradiation significantly increased the number of G2/M-phase cells, percentage of apoptotic cells, and γ-H2A.X level compared with FK866 or RT alone. We examined the effect of NAMPT inhibition on NMI and p53 expression in IOMM-Lee and TTMM705 cells. NAMPT inhibition by FK866 and shRNA treatment increased NMI, p53, CDKN1A and BAX expression. Additionally, we assessed the efficacy of FK866/RT combination treatment in vivo. The combination treatment exhibited increased antitumor efficacy compared with either treatment alone. The Ki67 level was significantly lower, and the p53 and γ-H2A.X levels were significantly higher in the combination treatment group than in the other three groups. In conclusion, these results indicate that FK866 improves radiosensitivity in malignant meningioma, an effect that may be attributed to the increase in p53 expression.

6 November 2024
Verified
Other
Open access
YLYifan Lv
Yifan Lv
YDYuxuan Deng
Yuxuan Deng
JFJie Feng
Jie Feng
JLJinqiu Liu
Jinqiu Liu
MYMingxu Yang
Mingxu Yang
SHShuyu Hao
Shuyu Hao
Surgical resection followed by radiotherapy (RT) is recommended for malignant meningioma, but poor outcome is unavoidable. To improve the efficacy of RT in malignant meningioma, a targeted radiosensitizer can be added. Nicotinamide phosphoribosyltransferase (NAMPT), highly expressed in high-grade meningiomas, may play a role in determining the radioresponse. Herein, we evaluated the impact of NAMPT inhibition on radiosensitivity in malignant meningioma in vivo and in vitro. IOMM-Lee and TTMM705 cells were treated with NAMPT inhibition (FK866 or shRNA NAMPT) before irradiation. The subsequent clonogenic assay demonstrated significantly increased radiosensitivity. Combination treatment with FK866 and irradiation significantly increased the number of G2/M-phase cells, percentage of apoptotic cells, and γ-H2A.X level compared with FK866 or RT alone. We examined the effect of NAMPT inhibition on NMI and p53 expression in IOMM-Lee and TTMM705 cells. NAMPT inhibition by FK866 and shRNA treatment increased NMI, p53, CDKN1A and BAX expression. Additionally, we assessed the efficacy of FK866/RT combination treatment in vivo. The combination treatment exhibited increased antitumor efficacy compared with either treatment alone. The Ki67 level was significantly lower, and the p53 and γ-H2A.X levels were significantly higher in the combination treatment group than in the other three groups. In conclusion, these results indicate that FK866 improves radiosensitivity in malignant meningioma, an effect that may be attributed to the increase in p53 expression.